Anticholinergic drugs block acetylcholine, a neurotransmitter critical for learning and memory. This class includes medications for urinary incontinence, Parkinson’s disease, and nausea, such as oxybutynin and scopolamine.
Long-term use of anticholinergics significantly increases dementia risk, particularly in older adults. For example, a decade-long observational study found a 54% increased risk of developing dementia among regular users compared to non-users.
Not all anticholinergics carry the same risk; some inhaled agents like tiotropium have not been linked to cognitive decline. Patients should discuss the necessity of these medications with their prescribers, considering potential safer alternatives or dosage adjustments.
- Identify anticholinergic medications in your regimen.
- Evaluate the risk-benefit ratio with a healthcare professional.
- Consider non-pharmacological approaches when feasible.
3. Corticosteroids
Corticosteroids such as prednisone and dexamethasone are indispensable for treating autoimmune and inflammatory conditions. However, chronic use, especially oral administration at high doses, can adversely affect brain health.
These drugs influence cortisol levels, which regulate stress responses and brain function. Excess cortisol can lead to mood disturbances, memory impairment, and increased dementia risk. Even inhaled corticosteroids, if used excessively, may contribute to cognitive side effects.
Healthcare providers should monitor cognitive symptoms in patients on long-term corticosteroids and explore the lowest effective doses or alternative therapies to minimize risks.
- Report any new memory or mood changes promptly.
- Use corticosteroids at the minimum effective dose.
- Discuss steroid-sparing options with your doctor.
